# A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer

> **NCT04241276** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 170 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** ATRA
- **DRUG:** Gemcitabine
- **DRUG:** nab-paclitaxel

## Key facts

- **NCT ID:** NCT04241276
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-04-30
- **Primary completion:** 2028-06-29
- **Final completion:** 2029-02-28
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04241276

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04241276, "A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04241276. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*